Peter C. Rüegg - Concepedia

Author

Peter C. Rüegg

Also Known As

Peter C. Ruegg, Peter C. Rüegg, Peter Ruegg, Peter Rüegg

Publications

184

Citations

H-Index

Concepts

All Affiliations

Peter C. Rüegg is an author at Novartis (Switzerland) specializing in pharmacotherapy, hypertension, and cardiovascular disease.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	25
2	Pharmacology	1	1	25
3	Hypertension	1	1	25
4	Atherosclerosis	1	1	25
5	Cardiovascular Disease	1	1	25

Peter C. Rüegg

Publications

151

Citations

H-Index

Page 1

	Year	Citations
Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects Joel Morganroth, Peter C. Rüegg, Cornelia Dunger‐Baldauf, The American Journal of Gastroenterology	2002	70
Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms James Fidelholtz, William Smith, James Rawls, The American Journal of Gastroenterology	2002	37
A multicenter evaluation of the safety, tolerability, and efficacy of isradipine in the treatment of essential hypertension Carl‐David Sundstedt, Peter C. Rüegg, Annemarie Keller, The American Journal of Medicine Non-pharmacological InterventionHypertensionHeart FailureCardiovascular DiseaseMedicine	1989	25
Tegaserod: Long-Term Treatment for Irritable Bowel Syndrome Patients with Constipation in Primary Care Peter Layer, Jutta Keller, Stefan Mueller‐Lissner, Digestion	2005	19

Page 1